(RTTNews) - Immatics N.V. (IMTX) Thursday reported updated data from the Phase 1b study of its ACTengine cell therapy IMA203 in melanoma patients. ACTengine is a personalized therapy in which a ...
Immatics has vaulted into phase 3 on the strength of early-stage data. The biotech is gearing up to start a pivotal trial of ...
(RTTNews) - Viking Therapeutics, Inc. (VKTX), Wednesday announced positive data from Phase 1b study of VK0214 in patients with X-linked adrenoleukodystrophy (X-ALD). X-ALD is a rare and often fatal ...
Target enrollment in the chronic cohort close to completionVancouver, British Columbia--( - September 30, 2024) - NervGen ...
BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, announced today preliminary safety data from ...
Poseida’s partnerships with Roche and Astellas aim to advance CAR-T therapies. See PSTX stock details and the impact of ...
BerGenBio announces safety data from phase 1b portion of BGBC016 study in first-line NSCLC: Bergen, Norway Tuesday, October 8, 2024, 15:00 Hrs [IST] BerGenBio ASA, a clinical-stag ...
The next phase of a Durango-La Plata County Airport terminal expansion is ready for takeoff after Wednesday’s groundbreaking ...
The City of Jackson began Phase 1A of the "Street Resurfacing Project" in October 2023. A year later, only 22 of 31 streets ...
Being Tested in Combination with MSD’s anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab) Cambridge, UK – 10 October 2024: Microbiotica, a clinical-stage biopharma company developing a pipeline of oral ...
Rockville, Maryland Saturday, October 5, 2024, 18:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback